Health Condition 1: N00-N99- Diseases of the genitourinary system
Conditions
Interventions
None listed
Sponsors
Faculty of Ayurveda Institue of Medical Sciences Banaras Hindu University
Eligibility
Inclusion criteria
Inclusion criteria: Patients willing to participate in the research work after giving well informed written consent, Women between age group 18 to 45 years (all nulliparous and multiparous women) having all or any signs & symptoms of Asrigdara as Excessive bleeding, Prolonged duration, Intermenstrual bleeding, Other than characteristics of menstrual blood
Exclusion criteria
Exclusion criteria: Age below 18 and above 45 years,Bleeding followed by abortion,Bleeding from the site other than the uterus,Any abnormalities detected in investigation ( routine and specific), Coagulation disorders, Patient suffering from chronic systemic diseases like uncontrolled hypertension, uncontrolled diabetes, venereal disease, Thyroid dysfunction, renal diseases, jaundice or any disorders influencing general physical health and ultimately influencing menses, Patient using IUCD & OCPs or injectable contraceptives & others, any history of allergy or allergy from trial, Central nervous system disorders like epilepsy, meningitis, migraine or any other psychological, Respiratory disorders like bronchial asthma, tuberculosis, pneumonia, pleural effusion, bronchitis, Cardiac disorders like angina, myocardial infarction, congenital anomaly of heart, Gastrointestinal disorders like appendicitis, cholecystitis, hepatitis, pancreatitis, cholelithiasis, diverticulitis, gastric ulcer, irritable bowel syndrome & others,organic pelvic pathology, benign and malignant tumors(Vulval, vaginal, rectal, cervical, uterine), PID, congenital anomalies of genital tract and different type of infections of genital, breast carcinoma, Patient is on chemotherapy/ radiotherapy for any malignant condition of any organ.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment will be done on the basis of prepared proforma and improvement in sign and symptoms of asrigdara 1Average Amount of menstrual blood loss 2 Normal Duration of menstrual blood loss 3 Normal Colour of menstrual blood loss 4 Normal Consistency of menstrual blood loss 5 Relief in Pain in abdomen during menses 6 Relief in Associated symptoms 7 Normal Endometrial thickness 8 Normal Serum Estradiol Timepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in criteria listed in different scalesTimepoint: Total four (4) follow-ups will be done at regular interval of one month or as per duration & interval of her menstrual cycle for 4 consecutive cycles, Three (3) follow ups will be done with medication and one (1) without medication to see the changes in parameters | — |
Countries
India
Contacts
Public ContactDR Varsha
Banaras Hindu university
Outcome results
None listed